Sep 30, 2024 8:01 am EDT ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
Sep 10, 2024 4:05 pm EDT ResMed to Host Its 2024 Investor Day on September 30, 2024, at the New York Stock Exchange
Aug 28, 2024 4:05 pm EDT ResMed Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
Aug 15, 2024 4:05 pm EDT ResMed Expands its Board of Directors and Appoints Healthcare Executive and Seasoned Finance Leader Christopher DelOrefice to its Board
Jun 10, 2024 9:05 am EDT PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia
May 23, 2024 9:05 am EDT Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy
May 16, 2024 4:35 pm EDT ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy
